Your browser doesn't support javascript.
loading
Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
Jain, Sanyog; Patel, Kamlesh; Arora, Sumit; Reddy, Venkata Appa; Dora, Chander Parkash.
Afiliación
  • Jain S; Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S, Nagar, Punjab, 160062, India. sanyogjain@niper.ac.in.
  • Patel K; Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S, Nagar, Punjab, 160062, India.
  • Arora S; Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S, Nagar, Punjab, 160062, India.
  • Reddy VA; Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S, Nagar, Punjab, 160062, India.
  • Dora CP; Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S, Nagar, Punjab, 160062, India.
Drug Deliv Transl Res ; 7(2): 292-303, 2017 04.
Article en En | MEDLINE | ID: mdl-28116656
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Olmesartán Medoxomilo / Antihipertensivos Límite: Animals Idioma: En Revista: Drug Deliv Transl Res Año: 2017 Tipo del documento: Article País de afiliación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Olmesartán Medoxomilo / Antihipertensivos Límite: Animals Idioma: En Revista: Drug Deliv Transl Res Año: 2017 Tipo del documento: Article País de afiliación: India